Antioxidants and CVD in diabetes: where do we stand now. - Wikidata - awgldk - TriplyDB

Antioxidants and CVD in diabetes: where do we stand now.

Antioxidants and CVD in diabetes: where do we stand now.

http://www.wikidata.org/entity/Q35201974

about

Aging and sleep: physiology and pathophysiology.Total serum bilirubin does not affect vascular reactivity in patients with diabetes Therapeutic interventions and oxidative stress in diabetes Protective role of grape seed proanthocyanidin antioxidant properties on heart of streptozotocin-induced diabetic rats.Plasma carotenoids and onset of dysglycemia in an elderly population: results of the Epidemiology of Vascular Ageing Study.Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat.Phloretin exerts hypoglycemic effect in streptozotocin-induced diabetic rats and improves insulin resistance in vitro.Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis.The plant extracts of Momordica charantia and Trigonella foenum-graecum have anti-oxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats.

P2860

Q30460885-555FD48C-BF62-4CA4-ADE0-2C7D4EBF9FF9 Q33430205-26934B10-19EE-4712-82D0-297AEE223897 Q33870395-7AA8F2FE-3943-4277-A504-ACB6EAEBDC31 Q35909340-DD06CA13-9119-45AD-8B62-03FAB65DF11B Q36756732-D48A350C-CE48-452F-A50D-B111742B902B Q37434847-3467F224-1B85-4EA2-8D5F-8C301F08D28E Q37638746-D28AB1B1-296D-47CF-954A-DD7E46C698F4 Q38094613-7C963E61-30C8-4CB4-939A-484E8C769E39 Q39534484-ECFB6558-2374-49DA-9960-452F2A1FA945 Q42323537-ECA5ECC4-0EAD-45D2-9597-FA4CD42388C7 Q49805961-5F2A0D8C-AB7E-4459-AB45-0CF98C93CAC9

P2860

Antioxidants and CVD in diabetes: where do we stand now.

http://www.wikidata.org/entity/Q35201974

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Antioxidants and CVD in diabetes: where do we stand now.

@ast

Antioxidants and CVD in diabetes: where do we stand now.

@en

type

label

Antioxidants and CVD in diabetes: where do we stand now.

@ast

Antioxidants and CVD in diabetes: where do we stand now.

@en

prefLabel

Antioxidants and CVD in diabetes: where do we stand now.

@ast

Antioxidants and CVD in diabetes: where do we stand now.

@en

P1433

Q35201974-127A2809-2E06-4DCB-82C2-71BCF002EE42

P1476

Q35201974-7BC86D42-BA6F-4337-AB2D-1E5383D4E997

P2093

Q35201974-06D98A50-CC93-498A-9468-089077F96B26

Q35201974-447D29E1-B60C-4BBB-BF68-462AB4232FC7

Q35201974-CDE7D4E9-8221-45EC-B0CA-DFD17306CB97

P2860

Q35201974-02405FDA-36E6-40E0-8E39-27CFBD3ADC75

Q35201974-0488182D-48E5-4BF7-B496-36A73FF0624E

Q35201974-054C9974-A5C7-449B-A962-AE5E231EBEF5

Q35201974-066801C5-E8F1-4F16-A45B-ADA1B3AAB904

Q35201974-13198711-4D2B-43E7-A741-8C7EB135E8AC

Q35201974-188946CB-9B56-402D-80B6-255684E0ABCB

Q35201974-1983C9A0-601A-4DE1-8E22-56127EA97015

Q35201974-215EEC9E-F7C7-4B28-A159-9546FC5D1BB9

Q35201974-27787DC9-A5A7-4518-9551-7DC5FCD0046F

Q35201974-2C934652-6D0F-4F0B-81A5-7457FF53DE9F

P2888

Q35201974-1D9C34EB-C2FE-4CE3-BC65-8C093C006984

P304

Q35201974-0265ADE5-97D6-4DAE-8ECD-D722EA530F9F

P31

Q35201974-65C93836-D5EC-4746-810E-1274AFD6B7FE

P356

Q35201974-401FB9DC-CB3F-41ED-8EC7-0F20C02F8CC9

P433

Q35201974-37662F20-BCEF-4888-977D-71BC4FA8459C

P478

Q35201974-47F3ECCE-F5CC-47E8-93E9-D337AF78AD1C

P577

Q35201974-6DDBF4CF-E7C1-4737-9B93-A80E62F1F5E2

P5875

Q35201974-64532F3A-BB64-4CF7-BD8F-95C4A40ED180

P698

Q35201974-4AD9C2CC-3FA5-4A0F-97C1-635E95EFC8FD

P932

Q35201974-97A4D46B-3E71-4799-8CDF-1FABD59F202C

P356

S11892-007-0003-9

P1433

Current diabetes report

P1476

Antioxidants and CVD in diabetes: where do we stand now.

@en

P2093

Aristidis Veves

http://www.w3.org/2001/XMLSchema#string

Atul Malhotra

http://www.w3.org/2001/XMLSchema#string

Susie Yim

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.

Biochemistry and molecular cell biology of diabetic complications

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

P2888

s11892-007-0003-9

P304

8-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-007-0003-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6548694

http://www.w3.org/2001/XMLSchema#string

P698

17254512

http://www.w3.org/2001/XMLSchema#string

P932

4368178

http://www.w3.org/2001/XMLSchema#string